A Registry of Patients with Type B Aortic Syndromes

Not Applicable

Recruiting

Conditions: Type B aortic syndromes
Cardiovascular - Diseases of the vasculature and circulation including the lymphatic system

Registration Number: ACTRN12620000435987

Lead Sponsor: Royal North Shore Hospital

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Recruiting

Sex: All

Target Recruitment: 200

Inclusion Criteria

Patients over the age 18 presenting at Royal North Shore Hospital, Sydney, NSW, and diagnosed with a type B aortic dissection. They must have given written consent.

Exclusion Criteria

Patients who do not wish to participate or give consent.

Study & Design

Study Type: Observational

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Survival duration after diagnosis with an aortic syndrome[ Follow up timepoints: <br>baseline<br>one week<br>3 months<br>6 months<br>1 year<br>and every 12 months thereafter for 10 years (end of registry), unless deceased, or consent withdrawn]

Secondary Outcome Measures

Name	Time	Method
The patient's health related quality of life following diagnosis will be assessed using the standardised EQ-5D (EuroQuol Group) which is a concise 5 question instrument that assesses quality of life outcomes. [ Follow up timepoints: <br>baseline<br>one week<br>3 months<br>6 months<br>1 year<br>and every 12 months thereafter for 10 years (end of registry), unless deceased, or consent withdrawn];The composite secondary outcome will include infection rate, endoleak and the need for repeat intervention. This will be assessed using data from analysis of surveillance imaging as well as review of medical records from outpatient follow-ups.[ Follow up timepoints: <br>baseline<br>one week<br>3 months<br>6 months<br>1 year<br>and every 12 months thereafter for 10 years (end of registry), unless deceased, or consent withdrawn]